Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$131.57
+0.2%
$129.71
$99.71
$141.23
$228.21B0.75.84 million shs3.89 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$163.68
+0.3%
$158.35
$140.68
$169.99
$394.53B0.477.61 million shs3.02 million shs
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
$556.05
-1.9%
$589.61
$493.86
$613.23
$589.23B1.0152.62 million shs39.42 million shs
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$44.97
+0.0%
$41.98
$37.59
$47.36
$189.26B0.4119.48 million shs10.42 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+4.12%+3.91%-3.21%+14.50%+16.04%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.97%+0.18%-1.75%+12.52%+3.33%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
-0.27%+0.28%-4.57%-4.69%+8.39%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
+1.82%+2.85%+2.89%+12.69%+8.30%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8386 of 5 stars
2.44.02.54.54.12.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.427 of 5 stars
2.33.04.23.93.52.50.6
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/AN/AN/AN/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
4.7129 of 5 stars
2.33.05.03.53.42.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.944.84% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.334.68% Upside
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
2.71
Moderate Buy$555.48-0.10% Downside
Verizon Communications Inc. stock logo
VZ
Verizon Communications
2.56
Moderate Buy$46.713.86% Upside

Current Analyst Ratings Breakdown

Latest SPY, ABT, JNJ, and VZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/25/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$42.00 ➝ $45.00
3/12/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $154.00
3/3/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$47.50 ➝ $48.00
2/19/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
2/3/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$162.00 ➝ $166.00
1/30/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$55.00 ➝ $55.00
(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.44$5.67 per share23.22$22.36 per share5.88
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.44$13.45 per share12.17$29.69 per share5.51
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/AN/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$134.79B1.40$9.37 per share4.80$23.89 per share1.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6517.2022.962.5231.95%20.74%11.19%4/16/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6524.6214.792.5618.20%34.24%13.63%4/15/2025 (Estimated)
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/A24.94N/AN/AN/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$17.51B$4.1410.869.254.4512.99%19.80%5.08%4/28/2025 (Estimated)

Latest SPY, ABT, JNJ, and VZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
1/24/2025Q4 2024
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$1.11$1.10-$0.01$1.19$35.49 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.79%N/A30.85%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.03%+5.43%74.59%63 Years
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
$7.071.27%N/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$2.716.03%+1.93%65.46%20 Years

Latest SPY, ABT, JNJ, and VZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
2/28/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
quarterly$0.67756.29%4/10/20254/10/20255/1/2025
1/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.43%2/18/20252/18/20253/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
1.21
0.63
0.59

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
63.54%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
62.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/A1.06 billionN/ANot Optionable
Verizon Communications Inc. stock logo
VZ
Verizon Communications
117,1004.21 billion4.21 billionOptionable

Recent News About These Companies

Was Jim Cramer Right About Verizon Communications Inc. (VZ)?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$131.57 +0.22 (+0.17%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$163.65 +0.52 (+0.32%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

SPDR S&P 500 ETF Trust stock logo

SPDR S&P 500 ETF Trust NYSEARCA:SPY

$555.94 -11.14 (-1.96%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products.

Verizon Communications stock logo

Verizon Communications NYSE:VZ

$44.97 +0.01 (+0.02%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.